RHON-KLINIKUM AG (0NQH) Price & Analysis

0 Followers

0NQH Stock Chart & Stats

€13.20

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€13.20

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€11.50 - €15.30

Previous CloseN/A

Volume0.00

Average Volume (3M)2.00

Market Cap

€977.30M

Enterprise Value€889.42

Total Cash (Recent Filing)€556.55M

Total Debt (Recent Filing)€121.88M

Price to Earnings (P/E)23.0

Beta-0.23

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.64

Shares Outstanding66,962,470

10 Day Avg. Volume1

30 Day Avg. Volume2

Financial Highlights & Ratios

PEG Ratio-1.22

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.64

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and declining debt provide RHÖN-KLINIKUM with financial resilience in a capital-intensive healthcare business. Rising equity of about €1.32bn adds a substantial cushion for investment, operational volatility, and future funding needs.

Strong 2025 Revenue GrowthThe strong 2025 rebound indicates renewed demand or improved activity across the hospital network. While growth has been uneven, higher revenue expands the base from which the company can improve utilization, absorb fixed costs, and rebuild profitability.

Established Cash-generating CapabilityRHÖN-KLINIKUM has demonstrated that its hospital operations can generate meaningful operating and free cash flow over multiple years. This supports reinvestment in facilities and services, although the latest deterioration means the capability requires monitoring.

Bears Say

Sharp EBIT DeteriorationThe steep operating-profit decline despite revenue growth points to significant cost pressure or adverse operating factors. If persistent, weak conversion of hospital activity into EBIT could constrain reinvestment, reduce returns, and undermine earnings durability.

Negative Latest Free Cash FlowNegative free cash flow reduces internal funding available for hospital infrastructure, technology, and service expansion. Although investment may explain part of the decline, continued weak cash conversion would increase reliance on the strong balance sheet.

Thin And Volatile ProfitabilityLow margins leave limited protection against wage inflation, energy costs, reimbursement pressure, or changes in patient mix. The alternating revenue performance further increases operating risk, making sustainable earnings improvement dependent on stronger cost control.

0NQH FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest share price was €11.50 and its highest was €15.30 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €977.30M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Nov 05, 2026 which is in 69 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on Aug 06, 2026. The company reported €0.135 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG does not currently pay dividends.

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.135 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in GB:0NQH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

1.39%

Trailing 12-Months

Asset Growth

-1.58%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.